These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31774274)

  • 1. Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling.
    Jariwala PB; Pellock SJ; Goldfarb D; Cloer EW; Artola M; Simpson JB; Bhatt AP; Walton WG; Roberts LR; Major MB; Davies GJ; Overkleeft HS; Redinbo MR
    ACS Chem Biol; 2020 Jan; 15(1):217-225. PubMed ID: 31774274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens.
    Ervin SM; Li H; Lim L; Roberts LR; Liang X; Mani S; Redinbo MR
    J Biol Chem; 2019 Dec; 294(49):18586-18599. PubMed ID: 31636122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.
    Bhatt AP; Pellock SJ; Biernat KA; Walton WG; Wallace BD; Creekmore BC; Letertre MM; Swann JR; Wilson ID; Roques JR; Darr DB; Bailey ST; Montgomery SA; Roach JM; Azcarate-Peril MA; Sartor RB; Gharaibeh RZ; Bultman SJ; Redinbo MR
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7374-7381. PubMed ID: 32170007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases.
    Biernat KA; Pellock SJ; Bhatt AP; Bivins MM; Walton WG; Tran BNT; Wei L; Snider MC; Cesmat AP; Tripathy A; Erie DA; Redinbo MR
    Sci Rep; 2019 Jan; 9(1):825. PubMed ID: 30696850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomics combined with activity-based proteomics point to gut bacterial enzymes that reactivate mycophenolate.
    Simpson JB; Sekela JJ; Graboski AL; Borlandelli VB; Bivins MM; Barker NK; Sorgen AA; Mordant AL; Johnson RL; Bhatt AP; Fodor AA; Herring LE; Overkleeft H; Lee JR; Redinbo MR
    Gut Microbes; 2022; 14(1):2107289. PubMed ID: 35953888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Regorafenib-Induced Toxicity through Inhibition of Gut Microbial β-Glucuronidases.
    Ervin SM; Hanley RP; Lim L; Walton WG; Pearce KH; Bhatt AP; James LI; Redinbo MR
    ACS Chem Biol; 2019 Dec; 14(12):2737-2744. PubMed ID: 31663730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amentoflavone from Selaginella tamariscina as a potent inhibitor of gut bacterial β-glucuronidase: Inhibition kinetics and molecular dynamics stimulation.
    Tian XG; Yan JK; Sun CP; Li JX; Ning J; Wang C; Huo XK; Zhao WY; Yu ZL; Feng L; Lv X; Ma XC
    Chem Biol Interact; 2021 May; 340():109453. PubMed ID: 33785314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.
    Pollet RM; D'Agostino EH; Walton WG; Xu Y; Little MS; Biernat KA; Pellock SJ; Patterson LM; Creekmore BC; Isenberg HN; Bahethi RR; Bhatt AP; Liu J; Gharaibeh RZ; Redinbo MR
    Structure; 2017 Jul; 25(7):967-977.e5. PubMed ID: 28578872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and Characterization of FMN-Binding β-Glucuronidases in the Human Gut Microbiome.
    Pellock SJ; Walton WG; Ervin SM; Torres-Rivera D; Creekmore BC; Bergan G; Dunn ZD; Li B; Tripathy A; Redinbo MR
    J Mol Biol; 2019 Mar; 431(5):970-980. PubMed ID: 30658055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics.
    Simpson JB; Walker ME; Sekela JJ; Ivey SM; Jariwala PB; Storch CM; Kowalewski ME; Graboski AL; Lietzan AD; Walton WG; Davis KA; Cloer EW; Borlandelli V; Hsiao YC; Roberts LR; Perlman DH; Liang X; Overkleeft HS; Bhatt AP; Lu K; Redinbo MR
    Cell Host Microbe; 2024 Jun; 32(6):925-944.e10. PubMed ID: 38754417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Investigation of Irinotecan Metabolism, Transport, and Gut Microbiome Activation.
    Parvez MM; Basit A; Jariwala PB; Gáborik Z; Kis E; Heyward S; Redinbo MR; Prasad B
    Drug Metab Dispos; 2021 Aug; 49(8):683-693. PubMed ID: 34074730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition and structure-activity relationship of dietary flavones against three Loop 1-type human gut microbial β-glucuronidases.
    Wang P; Wu R; Jia Y; Tang P; Wei B; Zhang Q; Wang VY; Yan R
    Int J Biol Macromol; 2022 Nov; 220():1532-1544. PubMed ID: 36096258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three structurally and functionally distinct β-glucuronidases from the human gut microbe
    Pellock SJ; Walton WG; Biernat KA; Torres-Rivera D; Creekmore BC; Xu Y; Liu J; Tripathy A; Stewart LJ; Redinbo MR
    J Biol Chem; 2018 Nov; 293(48):18559-18573. PubMed ID: 30301767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbial beta-glucuronidase and glycerol/diol dehydratase activity contribute to dietary heterocyclic amine biotransformation.
    Zhang J; Lacroix C; Wortmann E; Ruscheweyh HJ; Sunagawa S; Sturla SJ; Schwab C
    BMC Microbiol; 2019 May; 19(1):99. PubMed ID: 31096909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity.
    Wallace BD; Roberts AB; Pollet RM; Ingle JD; Biernat KA; Pellock SJ; Venkatesh MK; Guthrie L; O'Neal SK; Robinson SJ; Dollinger M; Figueroa E; McShane SR; Cohen RD; Jin J; Frye SV; Zamboni WC; Pepe-Ranney C; Mani S; Kelly L; Redinbo MR
    Chem Biol; 2015 Sep; 22(9):1238-49. PubMed ID: 26364932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid-induced microbial dysbiosis disrupts irinotecan (CPT-11) metabolism and increases gastrointestinal toxicity in a murine model.
    Meng J; Abu YF; Zhang Y; Zhou Y; Xie Y; Yan Y; Tao J; Ramakrishnan S; Chen C; Roy S
    Br J Pharmacol; 2023 May; 180(10):1362-1378. PubMed ID: 36562107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbial β-glucuronidases drive human periodontal disease etiology.
    Lietzan AD; Simpson JB; Walton WG; Jariwala PB; Xu Y; Boynton MH; Liu J; Redinbo MR
    Sci Adv; 2023 May; 9(18):eadg3390. PubMed ID: 37146137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organic Anion Transporting Polypeptide (OATP)2B1 Contributes to Gastrointestinal Toxicity of Anticancer Drug SN-38, Active Metabolite of Irinotecan Hydrochloride.
    Fujita D; Saito Y; Nakanishi T; Tamai I
    Drug Metab Dispos; 2016 Jan; 44(1):1-7. PubMed ID: 26526067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insight into the mechanism of Xiao-Chai-Hu-Tang alleviates irinotecan-induced diarrhea based on regulating the gut microbiota and inhibiting Gut β-GUS.
    Wang C; Teng X; Wang C; Liu B; Zhou R; Xu X; Qiu H; Fu Y; Sun R; Liang Z; Zhang R; Liu Z; Zhang L; Zhu L
    Phytomedicine; 2023 Nov; 120():155040. PubMed ID: 37683587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse Gut Microbiome-Encoded β-Glucuronidases Identified Using Metagenome Analysis Guided by Protein Structure.
    Creekmore BC; Gray JH; Walton WG; Biernat KA; Little MS; Xu Y; Liu J; Gharaibeh RZ; Redinbo MR
    mSystems; 2019 Aug; 4(4):. PubMed ID: 31455640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.